43 related articles for article (PubMed ID: 19754419)
1. Bicyclic Cyclohexenones as Inhibitors of NF-κB Signaling.
Hexum JK; Tello-Aburto R; Struntz NB; Harned AM; Harki DA
ACS Med Chem Lett; 2012 Jun; 3(6):459-464. PubMed ID: 22866208
[TBL] [Abstract][Full Text] [Related]
2. DrugMap: A quantitative pan-cancer analysis of cysteine ligandability.
Takahashi M; Chong HB; Zhang S; Yang TY; Lazarov MJ; Harry S; Maynard M; Hilbert B; White RD; Murrey HE; Tsou CC; Vordermark K; Assaad J; Gohar M; Dürr BR; Richter M; Patel H; Kryukov G; Brooijmans N; Alghali ASO; Rubio K; Villanueva A; Zhang J; Ge M; Makram F; Griesshaber H; Harrison D; Koglin AS; Ojeda S; Karakyriakou B; Healy A; Popoola G; Rachmin I; Khandelwal N; Neil JR; Tien PC; Chen N; Hosp T; van den Ouweland S; Hara T; Bussema L; Dong R; Shi L; Rasmussen MQ; Domingues AC; Lawless A; Fang J; Yoda S; Nguyen LP; Reeves SM; Wakefield FN; Acker A; Clark SE; Dubash T; Kastanos J; Oh E; Fisher DE; Maheswaran S; Haber DA; Boland GM; Sade-Feldman M; Jenkins RW; Hata AN; Bardeesy NM; Suvà ML; Martin BR; Liau BB; Ott CJ; Rivera MN; Lawrence MS; Bar-Peled L
Cell; 2024 May; 187(10):2536-2556.e30. PubMed ID: 38653237
[TBL] [Abstract][Full Text] [Related]
3. Carbon Free Radical (R⋅) Inactivates NF-κB for Radical Capping Therapy.
Zhao P; Li H; Sun B; Wang C; Lv G; Chen C; Ying L; He X; Jin D; Bu W
Angew Chem Int Ed Engl; 2024 Apr; ():e202405913. PubMed ID: 38683647
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide-based potential anti-inflammatory transcription inhibitors against nuclear factor NF-kappa-B p50 subunit (NF-κB p50): an integrated molecular and quantum mechanical approach.
Jain P; Sudandiradoss C
3 Biotech; 2023 Jan; 13(1):15. PubMed ID: 36540414
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization.
Zhang K; Jordan PM; Pace S; Hofstetter RK; Werner M; Chen X; Werz O
J Inflamm Res; 2022; 15():3285-3304. PubMed ID: 35676971
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Osteoclast Differentiation by Carotenoid Derivatives through Inhibition of the NF-ƙB Pathway.
Odes-Barth S; Khanin M; Linnewiel-Hermoni K; Miller Y; Abramov K; Levy J; Sharoni Y
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33238590
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Guaianolide Analogues with a Tunable α-Methylene-γ-lactam Electrophile and Correlating Bioactivity with Thiol Reactivity.
Jackson PA; Schares HAM; Jones KFM; Widen JC; Dempe DP; Grillet F; Cuellar ME; Walters MA; Harki DA; Brummond KM
J Med Chem; 2020 Dec; 63(23):14951-14978. PubMed ID: 33201697
[TBL] [Abstract][Full Text] [Related]
8. An Algal Metabolite-Based PPAR-γ Agonist Displayed Anti-Inflammatory Effect via Inhibition of the NF-κB Pathway.
Ju Z; Su M; Li D; Hong J; Im DS; Kim S; Kim E; Jung JH
Mar Drugs; 2019 May; 17(6):. PubMed ID: 31151271
[TBL] [Abstract][Full Text] [Related]
9. Helenalin Analogues Targeting NF-κB p65: Thiol Reactivity and Cellular Potency Studies of Varied Electrophiles.
Widen JC; Kempema AM; Baur JW; Skopec HM; Edwards JT; Brown TJ; Brown DA; Meece FA; Harki DA
ChemMedChem; 2018 Feb; 13(4):303-311. PubMed ID: 29349898
[TBL] [Abstract][Full Text] [Related]
10. Targeting NF-κB p65 with a Helenalin Inspired Bis-electrophile.
Widen JC; Kempema AM; Villalta PW; Harki DA
ACS Chem Biol; 2017 Jan; 12(1):102-113. PubMed ID: 28103680
[TBL] [Abstract][Full Text] [Related]
11. A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model.
Paneghetti L; Ng YS
Vasc Cell; 2016; 8():2. PubMed ID: 27175278
[TBL] [Abstract][Full Text] [Related]
12. Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.
Paranjpe A; Srivenugopal KS
Carcinogenesis; 2013 May; 34(5):990-1000. PubMed ID: 23354308
[TBL] [Abstract][Full Text] [Related]
13. Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Murray MC; Tazzari V; Sparatore A; Del Soldato P; Hines HB; Glynn SA; Ambs S; Wink DA
Cancer Res; 2012 May; 72(9):2394-404. PubMed ID: 22436383
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and redox mechanisms in the immune response.
Wink DA; Hines HB; Cheng RY; Switzer CH; Flores-Santana W; Vitek MP; Ridnour LA; Colton CA
J Leukoc Biol; 2011 Jun; 89(6):873-91. PubMed ID: 21233414
[TBL] [Abstract][Full Text] [Related]
15. Direct covalent modification as a strategy to inhibit nuclear factor-kappa B.
Pande V; Sousa SF; Ramos MJ
Curr Med Chem; 2009; 16(32):4261-73. PubMed ID: 19754419
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors.
Pande V; Ramos MJ
Curr Med Chem; 2005; 12(3):357-74. PubMed ID: 15723624
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NF-kappa B by S-nitrosylation.
Marshall HE; Stamler JS
Biochemistry; 2001 Feb; 40(6):1688-93. PubMed ID: 11327828
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor kappa B: a potential target for anti-HIV chemotherapy.
Pande V; Ramos MJ
Curr Med Chem; 2003 Aug; 10(16):1603-15. PubMed ID: 12871131
[TBL] [Abstract][Full Text] [Related]
19. Multiple redox regulation in NF-kappaB transcription factor activation.
Piette J; Piret B; Bonizzi G; Schoonbroodt S; Merville MP; Legrand-Poels S; Bours V
Biol Chem; 1997 Nov; 378(11):1237-45. PubMed ID: 9426183
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
